SIRT3
心肌梗塞
医学
丁酸钠
PLGA公司
药理学
自噬
化学
内科学
锡尔图因
生物化学
细胞凋亡
乙酰化
基因
体外
作者
Panke Cheng,Wen Zeng,Li Li,Da Huo,Lingqing Zeng,Ju Tan,Jingting Zhou,Jiansen Sun,Ge Liu,Yanzhao Li,Ge Guan,Yuxin Wang,Chuhong Zhu
标识
DOI:10.1002/advs.201600254
摘要
Acute myocardial infarction (AMI) is the death of cardiomyocytes caused by a lack of energy due to ischemia. Nutrients supplied by the blood are the main source of cellular energy for cardiomyocytes. Sodium butyrate (NaB), a gastrointestinal nutrient, is a short‐chain fatty acid (butyric acid) that may act as an energy source in AMI therapy. Poly(lactic‐co‐glycolic acid)‐Poly ( N ‐isopropylacrylamide) microspheres loaded with NaB (PP‐N) are synthesized to prolong the release of NaB and are injected into ischemic zones in a Sprague–Dawley rat AMI model. Here, this study shows that PP‐N can significantly ameliorate cardiac dysfunction in AMI, and NaB can specially bind to Sirt3 structure, activating its deacetylation ability and inhibiting the generation of reactive oxygen species, autophagy, and angiogenesis promotion. The results indicate that NaB, acting as a nutrient, can protect cardiomyocytes in AMI. These results suggest that the gastrointestinal nutrient NaB may be a new therapy for AMI treatment, and PP‐N may be the ideal therapeutic regimen.
科研通智能强力驱动
Strongly Powered by AbleSci AI